CD8A and neoplasm: IL-15 is a cytokine of great interest to the cancer immunotherapy field (8); it enhances anti-tumor responses through the stimulation of several leukocyte populations, including cytotoxic CD8+ T lymphocytes and NK (Natural Killer) cells (9–11).